Five-Year Follow-up of a Severe Case of Pertussis in Oregon, 2012

Juventila Liko1, William J Koenig2, Paul R Cieslak3

  • 1Oregon Immunization Program, Public Health Division, Oregon Health Authority, Portland, OR, USA.

Insights

Severe pertussis in infants can lead to lifelong health issues, including developmental delays and chronic conditions. This case highlights the critical need for maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination during pregnancy.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Infants under 2 months face the highest pertussis incidence and complications.
  • Oregon experiences ongoing pertussis (whooping cough) epidemics.

Purpose of the Study:

  • To detail the long-term medical course and sequelae of severe pertussis in an unvaccinated infant.
  • To emphasize the importance of maternal pertussis vaccination.

Main Methods:

  • Case report describing the medical journey of an infant with severe pertussis from infancy to age 5½.
  • Longitudinal follow-up of developmental milestones, medical interventions, and chronic health outcomes.

Main Results:

  • The infant experienced severe pertussis with significant complications.
  • Sequelae include developmental delays, chronic lung disease, stroke, epilepsy, neurodevelopmental impairment, and vision problems.
  • The child requires ongoing substantial medical care.

Conclusions:

  • Untreated pertussis in infants carries a severe, long-term burden.
  • Prenatal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination is crucial for protecting infants too young to be vaccinated.
  • Maternal vaccination is key to preventing infant pertussis morbidity and mortality.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
792
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.6K